Action mechanism of atypical antipsychotics and vista of drug discovery
文献类型:期刊论文
作者 | LIU HuiFang2; FU Wei2; JIN GuoZhang1![]() |
刊名 | Chinese Journal of Pharmacology and Toxicology
![]() |
出版日期 | 2008 |
卷号 | 22期号:6页码:470-476 |
关键词 | antipsychotics schizophrenia receptors,dopamine receptors, serotonin |
ISSN号 | 1000-3002 |
其他题名 | 非经典抗精神病药作用机制及药物发现展望 |
文献子类 | Review |
英文摘要 | In the past 10 years, atypical antipsychotics were developed to be the second generation of medicine without extrapyramidal symptoms side effects to treat schizophrenia. This paper summarizes the structural feature, therapeutic effect of several representative atypical antipsychotics and their binding mechanism with target receptors at molecular levels. In addition, it also classifies atypical antipsychotics, based on their binding mechanism with target receptors. Finally a new clue for drug design and discovery of novel atypical antipsychotics with less side effects was provided. |
资助项目 | 国家自然科学基金资助项目(20702009)[00000000] ; 中国博士点新教师基金资助课题(20070246092)[00000000] |
WOS研究方向 | Pharmacology & Pharmacy (provided by Clarivate Analytics) |
语种 | 中文 |
CSCD记录号 | CSCD:3449692 |
源URL | [http://119.78.100.183/handle/2S10ELR8/268064] ![]() |
专题 | 院士及顾问专家 |
通讯作者 | JIN GuoZhang |
作者单位 | 1.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. 2.Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 200032, China.; |
推荐引用方式 GB/T 7714 | LIU HuiFang,FU Wei,JIN GuoZhang. Action mechanism of atypical antipsychotics and vista of drug discovery[J]. Chinese Journal of Pharmacology and Toxicology,2008,22(6):470-476. |
APA | LIU HuiFang,FU Wei,&JIN GuoZhang.(2008).Action mechanism of atypical antipsychotics and vista of drug discovery.Chinese Journal of Pharmacology and Toxicology,22(6),470-476. |
MLA | LIU HuiFang,et al."Action mechanism of atypical antipsychotics and vista of drug discovery".Chinese Journal of Pharmacology and Toxicology 22.6(2008):470-476. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。